Dr. Parnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3070 Kerner Blvd.
Suite A
San Rafael, CA 94901Phone+1 415-256-1800
Summary
- Francis Parnell, MD, is an otolaryngologist in San Rafael, CA, specializing in ENT. He completed his medical education at Georgetown University School of Medicine in 1965, followed by an internship and residency in Otolaryngology-Head and Neck Surgery at the University of Wisconsin Hospitals and Clinics. Dr. Parnell has been the Founder, Chairman, and CEO of Parnell Pharmaceuticals, Inc. since 1987. He has authored several publications, including works on petrositis and vocal cord paralysis. His achievements have earned him recognition in Whos Who in America. He is a 50-year Fellow of the American College of Surgeons.
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Otolaryngology - Head and Neck Surgery, 1966 - 1970
- University of Wisconsin Hospitals and ClinicsInternship, Otolaryngology - Head and Neck Surgery, 1965 - 1966
- Georgetown University School of MedicineClass of 1965
Certifications & Licensure
- CA State Medical License 1970 - 2026
- NV State Medical License 2023 - 2025
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- US Alternate Delegate World Heald Health Organization, 1974
- Whos Who in America Marquis Whos Who
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- World population year.F W Parnell
American Journal of Public Health. 1974-10-01 - Tomography in the diagnosis of petrositis.Francis W. Parnell, James H. Brandenburg, John D. Swingle
The Annals of Otology, Rhinology, and Laryngology. 1974-03-01 - Tomography in the diagnosis of petrositis.Francis W. Parnell, James H. Brandenburg, John D. Swingle
Transactions of the Pacific Coast Oto-Ophthalmological Society Annual Meeting. 1972-01-01
Press Mentions
- New Antiviral COVID-19 Treatment to Be Used as Nasal Spray Could Be Made Available over the CounterSeptember 8th, 2020
- Parnell Pharmaceuticals Develops Nasal Spray to Fight Against COVID-19September 2nd, 2020
Professional Memberships
- Member
- Member
- Member
Industry Relationships
- Corporate Medical Director, Becton Dickenson & Co. (BD)1975 - 1978
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: